BBSRC Impact Acceleration Account (IAA)

The broad aim of the BBSRC Impact Acceleration Account (IAA) is to facilitate the impact agenda, including forging new collaborations with industry and strengthening existing external, non-academic collaborations. One key aspect of this is to support knowledge exchange and early-stage commercialisation projects to the point at which further funding can be successfully sought.

The scheme is open to researchers (no previous BBSRC funding is required). IAA awards can be up to £25k in value, with project durations up to 12 months.

Funds can be used for: 

  • Facilitate impact agendas including forging new collaborations with industry and strengthening existing external, non-academic collaborators. (External collaborators usually received favourably). 
  • Strengthening user engagement.
  • Strengthening the KE through culture and capability development, including through the development of skills for KE activity.
  • Supporting KE and commercialisation at early stages of progressing research outputs and outcomes to the point when they would be supported by further funding (e.g., FoF).
    • Early-stage translational projects to take them on the next steps along the translational pathway. Open to PIs with current or past funding. 
    • Projects include prototype evaluation, PoC, pump-priming of initial trials and scoping exercises. 
  • Supporting new, innovative and imaginative approaches to KE and Impact, including processes that enable “fast failure” and appropriate learning.
  • Supporting activities that enable impact to be achieved in an effective and timely manner, including secondments and people exchange. 
  • IAA funds can also be used to support market assessment, development of business cases, talent mobility, industry champion support as well as costs towards industry-based events.

Funds cannot be used for:  

  • Patent filing or similar costs associated directly to registering intellectual property rights.
  • Non-specific Public Engagement activities and science communication (specific activities designed to have specific impact upon a specific public may be acceptable).
  • New research.
  • Infrastructure and Capital Expenditure, i.e. no single items of equipment above the £10k threshold are permitted.
  • Undergraduate activities, core PhD training, masters degrees.
  • Other costs not allowed in the BBSRC/RCUK Standard Research Grant T&Cs. 


Application process
Applications should be made via the TRI Joint Application Form.

This call is currently closed - next funding round due to open April 23. However, if you have a project in mind or would like to enquire for further information, please contact Louise Mason. We may be able to advise on other sources of internal and external funding and support.

Funded Projects

Principle Investigator Project Title
David Eckersall Accelerating the impact of veterinary biomarker discovery
John Gordon, Caroline Woodside One health show case and networking event
Cheryl Woolhead Characterisation of the ion channels using cell-free expression in microfluidic format
Graeme Milligan Developing strategic links with Biopta to support development of a novel anti-asthma concept
Douglas Morrison Inulin Proprionate Ester: a novel food ingredient for appetite suppression and weight management
Sara Macdonald, Caroline Woodside Policy Research Day - driving Impact through policy-relevant research excellence
Sarah Cleaveland, Jo Sharp, Ruth Zadoks, Jo Halliday Delivering key disease prevention messages to health care providers in Tanzania
Louise Matthews, Richard Reeve Promoting impact in the Boyd Orr Centre for Population and Ecosystem Health
Penelope Tsimbouri, Matthew Dalby NanoKick bioreactor - usefulness in cancer research
Shireen Davies, Julian Dow Novel insect control reagents for Food Security
Dan Haydon Developing a platform for communicating impacts of infectious disease research in real-time
Matt Dalby Giving Stem Cells a Good (Nano)Kicking – Royal Society Summer Exhibition.
Matt Dalby CeMI Industry day
Karl Burgess RT Met
Julian Dow, Shireen Davies Market research - Kidney nephrotoxicity
Joel Milner Bacteriocins as a seed treatment: A novel method for protecting plants against bacterial pathogens.
Martin Llewellyn Aquaculture screening market assessment
Martin Llewellyn SalmoSim
Martin Llewellyn AquaScan
Caroline Gauchotte-Lindsay Delivery of a Fully Automated On-line Position Specific Isotope Analysis Inlet 
Kostas Tokatlidis Mitotargin
Shireen Davies Biopesticide Product Development
Alicia Davis Operationalising One Health Interventions in Tanzania—District Engagement
Jude Robinson Exploring the role of (digital) storytelling to engage people and communities in Everyday Clean WaSH interventions
David Eckersall Veterinary biomarker development and clinical validation
Martin Llewellyn In situ eDNA monitoring of planktonic threats to salmon aquaculture using a paper-based PCR device
Martin Llewellyn SalmoSim: Processing in vivo trial data
Sarah Cleaveland Towards large-scale adoption of cattle vaccines against malignant catarrhal fever in East Africa
Jim Brewer Market-led proof of concept data generation for vaccine adjuvant portfolio 
Rucha Karnik Sci-Seedlets 
Harry de-Koning A combination treatment for the fatal horse disease dourine
Marieke Pingen  Post-Academic Career Mentorship & Advice Network (PACMAN) Event
Joel Milner Bacteriocin Commercial Scoping